A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 365 participants.
Also called NCT02345057
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 365 participants
- Sponsor
- Registry
-
NCT02345057
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02345057. Randomized; quadruple masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2016-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria
- Condition
- Diabetic Nephropathy
- Intervention (Drug)
- CS-3150
- Intervention (Drug)
- placebo
- Lead sponsor
- Daiichi Sankyo
Record details
- Record id
cardio:ct-nct02345057- Content hash
52ea4c0f740ec10593f5827ac1b8375f7111e721fde4c5b3ff4ae5939800105f